'Most in 89 Days' New Confirmed Cases 668... 74 Additional Vaccine Adverse Reactions Reported (Update)

Local Cases 653, Imported Cases 15

[Image source=Yonhap News]

[Asia Economy Reporter Kim Ji-hee] On the 7th, the number of new domestic COVID-19 cases recorded 668, the highest number in 89 days since January 8.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on this day, the number of new domestic COVID-19 cases increased by 668, bringing the total to 106,898. Regarding the infection routes, 653 cases were locally transmitted, and 15 cases were imported from overseas.

By region, in the metropolitan area, Seoul reported 196 cases, Gyeonggi 73 cases, and Incheon 44 cases. Cases also increased evenly in non-metropolitan areas. In Daejeon, 61 people tested positive in a cluster, and 38 cases were confirmed in Busan. Following that, Ulsan reported 26 cases, Gyeongnam 25, Daegu and Gangwon each 16, Chungbuk 15, Chungnam 11, Jeonbuk 10, Gyeongbuk 9, Jeonnam 7, Jeju 3, Gwangju 2, and Sejong 1, with confirmed cases occurring in all regions.

The cumulative number of COVID-19 deaths increased by 4 from the previous day, reaching 1,756. The number of critically ill patients decreased by 3 from the previous day to 109. The number of patients who were declared recovered and released from isolation increased by 565 to 97,928.

On this day, the number of suspected case tests was 44,877, and the number of tests at temporary screening clinics in the metropolitan area was 38,440. Ninety confirmed cases were identified at the metropolitan temporary screening clinics.

Meanwhile, the COVID-19 Vaccination Response Promotion Team reported that as of midnight on this day, 37,533 people received their first dose, bringing the total number of people who completed the first dose to 1,039,066. The number of new second-dose vaccinations was 5,722, with a cumulative total of 33,414. So far, 887,452 people have received the AstraZeneca vaccine, and 151,614 have received the Pfizer vaccine.

The number of suspected adverse reactions reported after COVID-19 vaccination increased by 74 from the previous day, totaling 11,215. Among the newly reported adverse reaction cases, there was 1 suspected case of anaphylaxis. Death cases increased by 2. The rest were mild symptoms such as muscle pain and headache.

This content was produced with the assistance of AI translation services.